At Limenbio, we’re developing our patented High-Pressure gas perfusion (HIPPER) technology for preservation of donor hearts.
Our mission is to extend viability windows, improve patient outcomes, and redefine global logistics for transplant medicine.
This company has no teams yet
This company has no offices yet